Targeting Insulin Resistance and Liver Fibrosis: CKD Screening Priorities in MASLD
<b>Background and Aims:</b> Chronic kidney disease (CKD) is a recognized extra-hepatic disease of nonalcoholic fatty liver disease (NAFLD). With the redefinition of NAFLD as metabolic dysfunction-associated steatotic liver disease (MASLD), the importance of cardiovascular metabolic facto...
Saved in:
| Main Authors: | Tianyuan Yang, Bingqing Yang, Jingya Yin, Chenxue Hou, Qi Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-04-01
|
| Series: | Biomedicines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9059/13/4/842 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Readily Available Index of Insulin Sensitivity Is Associated with Metabolic Dysfunction-Associated Steatotic Liver Disease and Liver Fibrosis in Patients with Type 2 Diabetes
by: Stefano Ciardullo, et al.
Published: (2025-06-01) -
The relationship between the ratio of non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol (NHHR) and both MASLD and advanced liver fibrosis: evidence from NHANES 2017–2020
by: Juyi Li, et al.
Published: (2025-02-01) -
Cost-effectiveness of advanced hepatic fibrosis screening in individuals with suspected MASLD identified by serologic noninvasive tests
by: Huiyul Park, et al.
Published: (2025-07-01) -
Development and validation of a scoring system to predict MASLD patients with significant hepatic fibrosis
by: Linjing Long, et al.
Published: (2025-03-01) -
Significant Within-Individual Variability in VCTE Liver Stiffness Measurements at Two Intercostal Spaces in Subjects with MASLD: Implications for Evaluating Improvement in Liver Fibrosis After Weight-Loss or Liver-Directed Therapy
by: Jordan S. Woodard, et al.
Published: (2024-11-01)